Molecular Characterization of Hepatitis C Virus for Developed Antiviral Agents Resistance Mutations and New Insights into in-silico Prediction Studies

BACKGROUND: Identification and characterization of developed antiviral drug resistance mutations are key to the success of antiviral therapies against hepatitis C virus (HCV), which remains a worldwide highly prevalent pathogenic disease. Although most studies focus on HCV genotypes 1, 2 or 3, the i...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Sokkary, Mohamed M Adel, Gotina, Lizaveta, Al-Sanea, Mohammad M, Pae, Ae Nim, Elbargisy, Rehab Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696641/
https://www.ncbi.nlm.nih.gov/pubmed/33262618
http://dx.doi.org/10.2147/IDR.S267809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696641/
https://www.ncbi.nlm.nih.gov/pubmed/33262618
http://dx.doi.org/10.2147/IDR.S267809

Ejemplares similares